Pacific Growth Upgrades Illumina Stock ... | GenomeWeb

NEW YORK, May 24 (GenomeWeb News) - An analyst at Pacific Growth Equities upgraded Illumina stock yesterday to "buy" from "neutral" after the company on Firday said it will sell 3.5 million shares of its common stock.


As GenomeWeb News reported last week, Illumina expects to pocket around $83.6 million from the sale.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.